Immutep

Contact Us

Immutep S.A. au capital de 247 136 euros- 439 518 663 RCS Evry Siège social : Parc Club Orsay, 2, rue Jean Rostand, 91893 ORSAY



Filling this form is the simpliest way to contact us by email.


If you wish to visit us, please click here for full maps and details.

First Name :

Last Name :

Company (blank if none) :

Title (blank if none) :

Address :

Town :

Zip Code :

Country :

Telephone :

Fax :

E-mail address :

<~ only this field is really required
 

Type in your comments or questions. An Immutep staff member will get back to you shortly.

» Visit Us
© 2002 Immutep, S.A.
Press Release
06/2008 - LAG-3 Enhances Activity of a Cellular Cancer Immunotherapy
image Immutep S.A. announced today the publication of research conducted by ...
11/2007 - IMP321 first results in metastatic breast cancer
image Immutep S.A announced positive interim results from a Phase I/II ...
09/2007 - IMP321’s potency as a new immunopotentiator in cancer patients
image Immutep Announces That ImmuFact® IMP321 Induces Activation of a Wide ...
09/2007 - Entering Phase I
image lmmutep Announces That ImmuFact IMP321 Has Entered a Phase I ...
10/2006 - Entering Phase I
image lmmutep Announces That ImmuFact IMP321 Has Entered a Phase I ...